Hogehilweg 18 Mon-Fri 08:30-17:30
MijnMedicijn
📞 Contact phone — free, 24/7
Medications

Hiv

Antiretroviral medications and related products for HIV prevention, treatment, and management, including PrEP and PEP, viral load and self-testing kits, drugs for opportunistic infections, treatment monitoring tools, adherence aids, and informational resources for people living with HIV.

1
Products
1 products found
−20%
Nevirapine
★★★★☆ 4.5 (61)
€6,87
€5,49
Buy Now

Hiv

Antiretroviral medications and related products for HIV prevention, treatment, and management, including PrEP and PEP, viral load and self-testing kits, drugs for opportunistic infections, treatment monitoring tools, adherence aids, and informational resources for people living with HIV.

This category covers antiretroviral medications used to treat and manage human immunodeficiency virus (HIV) infection. These drugs work to reduce the amount of virus in the blood, help preserve and restore immune function, and lower the risk of HIV-related illnesses. Products in this area include single agents and combination formulations that are prescribed as part of a structured treatment plan intended to maintain long-term viral suppression rather than provide a one-time cure.

Typical uses include chronic treatment for people living with HIV, part of post-exposure prophylaxis (PEP) after potential recent exposure, and components of prevention strategies such as pre-exposure prophylaxis (PrEP) in specific clinical settings. Some medicines in this category also have activity against hepatitis B virus and may be used where co-infection exists; formulations developed for hepatitis B use may appear alongside HIV treatments because of overlapping antiviral properties.

Medications are grouped into classes based on how they act against the virus. Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs) interrupt viral replication at the reverse transcription step, protease inhibitors (PIs) disrupt viral protein processing, and integrase strand transfer inhibitors (INSTIs) block integration of viral DNA into human cells. Examples often encountered include lamivudine (branded as Epivir and as Epivir-HBV for hepatitis B formulations), efavirenz (branded as Sustiva), and lopinavir/ritonavir combinations (branded as Kaletra). Many regimens combine drugs from different classes to increase efficacy and reduce the chance of resistance development.

How these medicines are taken varies by product: most are oral tablets or capsules taken once or more times daily, while some have formulations for children or for people who cannot swallow pills. Fixed-dose combinations simplify regimens by putting two or more active drugs into a single pill, which can reduce pill burden and support adherence. Initiation and choice of regimen are individualized based on viral characteristics, prior treatment history, coexisting health conditions, potential drug interactions, and patient preferences.

Safety considerations include possible side effects such as gastrointestinal symptoms, sleep or mood changes, lipid or metabolic alterations, and effects on liver or kidney function depending on the specific agent. Drug–drug interactions are an important concern because several antiretrovirals affect the metabolism of other medicines. Long-term use can also lead to drug resistance if viral replication is not fully suppressed. For these reasons, ongoing clinical monitoring and appropriate laboratory testing are part of standard care when these medicines are used.

When choosing a product from this category, users commonly look for information about the active ingredients, dosing schedule, pill size and frequency, whether pediatric or special formulations exist, and known side effect profiles. Other considerations include whether a medication covers co-infections like hepatitis B, the availability of generic versions, and whether the formulation fits lifestyle needs such as once-daily dosing or combination pills that reduce the number of tablets. These factors, together with professional clinical assessment, determine which antiretroviral options are clinically appropriate for an individual.

Jeroen van den Berg
Medically reviewed by
Jeroen van den Berg
Registered Pharmacist (Apotheker), Chief Pharmacist and Head of Pharmacy Department